Navidea Biopharmaceuticals Inc

ASE:NAVB   2:37:42 PM EDT
+0.02 (+2.29%)
Earnings Announcements

Navidea Biopharmaceuticals Reports First Quarter 2022 Financial Results

Published: 05/12/2022 11:39 GMT
Navidea Biopharmaceuticals Inc (NAVB) - Navidea Biopharmaceuticals Reports First Quarter 2022 Financial Results.
Navidea Biopharmaceuticals Inc - Qtrly Loss per Share $0.10.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.